CASEY BOLTON: Open Payments
NPI 1629462056 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 19 payments from 12 companies in 2025. Trend: 2023 $409 · 2024 $404 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $35 |
| Eisai Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Ionis Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: Kerendia, JARDIANCE, Wegovy, Leqembi, QULIPTA, The Cologuard Plus Collection Kit, VOQUEZNA, TRYNGOLZA.
Industry payments across GA — which companies pay providers there.
